VCYT — VERACYTE, INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1384101 ·
Last close
$24.23
Market Cap
$1.96B
52W High
$60.91
52W Low
$21.91
ADV30
2,296,247
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 150,321,000 | 108,549,000 | 22,980,000 | 25,490,000 | 1,486,366,000 | 299,521,000 | 97,963,000 |
| Mar 2026 | 139,071,000 | 101,159,000 | 22,646,000 | 28,707,000 | 1,436,400,000 | 263,136,000 | 91,994,000 |
| Dec 2025 | 140,636,000 | 101,973,000 | 39,908,000 | 41,149,000 | 1,406,019,000 | 362,578,000 | 96,443,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$178,381,000
Investing CF
$-98,673,000
Financing CF
$338,000
CapEx
$-12,393,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.55
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-323,433,000
Inventory
$22,656,000
Receivables
$54,177,000
ST Investments
$185,711,000
EBIT TTM
$116,020,000
Pretax Income TTM
$116,020,000
Interest Exp TTM
$0
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$581,782,016
EBITDA
$108,943,000
Free Cash Flow
$110,915,752
Enterprise Value
$1,619,806,848
Total Cash
$370,532,000
Total Debt
$40,736,000
Shares Out
80,695,480
Trailing EPS
$1.54
Book Value
$17.77
ROE
9.4%
ROA
3.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 517,145,000 | 78,282,000 | 66,353,000 | 1,406,019,000 | 96,443,000 | 1,309,576,000 | 136,307,000 |
| Dec 2024 | 445,764,000 | 19,510,000 | 24,138,000 | 1,300,035,000 | 124,069,000 | 1,175,966,000 | 75,096,000 |
| Dec 2023 | 361,051,000 | -17,446,000 | -74,404,000 | 1,114,906,000 | 70,804,000 | 1,044,102,000 | 44,222,000 |
| Dec 2022 | 296,536,000 | -35,340,000 | -36,560,000 | 1,156,422,000 | 81,222,000 | 1,075,200,000 | 7,535,000 |
TTM Snapshot
Revenues TTM
$561,900,000
NetIncome TTM
$114,483,000
OpCashFlow TTM
—
Assets (Latest)
$1,486,366,000
Forward EPS
$1.83
Max Pain — expiry 2026-12-18
max pain strike: $25.00 · spot: $25.57 · call oi: 1,322 · put oi: 383
Expected Move to 2026-12-18:
±$3.80
(14.86%) —
implied range
$21.77 –
$29.37
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AGL | agilon health, inc. | $1.93B | $115.20 | — |
| FTRE | Fortrea Holdings Inc. | $1.89B | $19.59 | — |
| BKD | Brookdale Senior Living Inc. | $2.10B | $8.80 | — |
| ADUS | Addus HomeCare Corp | $2.27B | $121.56 | — |
| HCSG | HEALTHCARE SERVICES GROUP INC | $1.66B | $24.69 | — |
News headlines (Yahoo Finance, 1h cache)
Veracyte (VCYT) Reset Decipher Growth Expectations, Is The Discount Now Too Wide?
2026-11-07 07:11 · Yahoo
Why Is Veracyte (VCYT) Drawing Attention For Its Decipher Prostate Test?
2026-11-06 21:16 · Yahoo
Veracyte Q3 Earnings Call Highlights Slower Growth and Added Investment
2026-11-06 16:10 · Yahoo
Veracyte Crashes Almost 60% On A Seismic Shift. Analysts Decipher What Went Wrong.
2026-11-05 21:22 · Yahoo
Veracyte (VCYT) Q3 2026 Earnings Call Transcript
2026-11-05 19:46 · Yahoo
Veracyte Inc (VCYT) Q3 2026 Earnings Call Highlights: Revenue Climbs 15% as Afirma Shines and ...
2026-11-05 11:11 · Yahoo
What Veracyte (VCYT) Said on Its Q3 Earnings Call
2026-11-05 09:14 · Yahoo
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates
2026-11-04 23:45 · Yahoo
Veracyte: Q3 Earnings Snapshot
2026-11-04 22:47 · Yahoo
Veracyte Announces Third Quarter 2026 Financial Results
2026-11-04 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.